Daily Stock Analysis, EDGE, Edge Therapeutics Inc, priceseries

Edge Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
0.41
Close
0.41
High
0.43
Low
0.39
Previous Close
0.39
Daily Price Gain
0.02
YTD High
0.54
YTD High Date
Jan 7, 2019
YTD Low
0.30
YTD Low Date
Jan 2, 2019
YTD Price Change
0.05
YTD Gain
14.36%
52 Week High
17.77
52 Week High Date
Mar 12, 2018
52 Week Low
0.28
52 Week Low Date
Dec 28, 2018
52 Week Price Change
-15.09
52 Week Gain
-97.34%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Sep 26. 2017
9.85
Oct 11. 2017
10.62
11 Trading Days
7.79%
Link
LONG
Jan 17. 2018
10.66
Mar 1. 2018
14.50
30 Trading Days
36.06%
Link
Company Information
Stock Symbol
EDGE
Exchange
NasdaqGS
Company URL
http://www.edgetherapeutics.com
Company Phone
800-208-3343
CEO
Brian A. Leuthner
Headquarters
New Jersey
Business Address
300 CONNELL DRIVE, SUITE 4000, BERKELEY HEIGHTS, NJ 07922
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001472091
About

Edge Therapeutics, Inc. operates as biotechnology company which develops therapies. engages in the discovery, development, and commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions for which limited or no current therapies exist. It develops the Precisa Platform of EG-1962 and the EG-1964 treatments. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.

Description

Developing a sustained-release therapy for limiting brain injury after aneurysms.